Clonal relationship between multidrug-resistant Escherichia coli ST69 from poultry and humans in Lusaka, Zambia.


Journal

FEMS microbiology letters
ISSN: 1574-6968
Titre abrégé: FEMS Microbiol Lett
Pays: England
ID NLM: 7705721

Informations de publication

Date de publication:
12 02 2022
Historique:
received: 21 10 2021
revised: 05 01 2022
accepted: 12 01 2022
pubmed: 15 1 2022
medline: 5 3 2022
entrez: 14 1 2022
Statut: ppublish

Résumé

Multidrug-resistant (MDR) Escherichia coli in food animals such as chickens is an emerging public health concern in Zambia. Additionally, the country's high demand for poultry products necessitates further investigation into the link between poultry and human MDR E. coli. Twenty cefotaxime-resistant E. coli isolates collected from poultry in Lusaka, Zambia, were screened for multidrug resistance and sequenced on MiSeq and MinION platforms. Genomes were assembled de novo and compared with 36 previously reported cefotaxime-resistant E. coli isolates from inpatients at the University Teaching Hospital, Lusaka. All (20/20, 100%) poultry isolates exhibited resistance to ampicillin, chloramphenicol and doxycycline. Phylogenetic analysis and hierarchical clustering showed a high degree of genetic relatedness between E. coli O17:H18-ST69 from poultry and humans. The E. coli O17:H18-ST69 clone accounted for 4/20 (20%) poultry- and 9/36 (25%) human-associated isolates that shared two plasmids harboring 14 antimicrobial resistance (AMR) genes. However, comparison analysis showed that the isolates also had other AMR plasmids distinct for each niche. Our results suggested clonal transmission of MDR E. coli between poultry and humans, with the potential acquisition of niche-specific AMR plasmids. Thus, the control of MDR E. coli requires a One Health approach involving both human and animal health sectors.

Identifiants

pubmed: 35030252
pii: 6507559
doi: 10.1093/femsle/fnac004
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of FEMS.

Auteurs

Misheck Shawa (M)

Division of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, 001-0020, Japan.

Yoshikazu Furuta (Y)

Division of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, 001-0020, Japan.

Atmika Paudel (A)

Division of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, 001-0020, Japan.

O'Brian Kabunda (O)

Bacteriology Unit, Central Veterinary Research Institute, Lusaka, 10101, Zambia.

Evans Mulenga (E)

Department of Paraclinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka, 10101, Zambia.

Maron Mubanga (M)

Department of Paraclinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka, 10101, Zambia.

Harvey Kamboyi (H)

Division of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, 001-0020, Japan.

Tuvshinzaya Zorigt (T)

Division of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, 001-0020, Japan.

Herman Chambaro (H)

Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, 001-0020, Japan.

Manyando Simbotwe (M)

Department of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka, 10101, Zambia.

Bernard Hang'ombe (B)

Department of Paraclinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka, 10101, Zambia.

Hideaki Higashi (H)

Division of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Sapporo, 001-0020, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH